LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 64532

Search options

  1. Article ; Online: Zhen-Wu decoction and lactiflorin, an ingredient predicted by in silico modelling, alleviate uremia induced cardiac endothelial injury via Nrf2 activation.

    Liu, Xin / Li, Yue / Ni, Shi-Hao / Sun, Shu-Ning / Deng, Jian-Ping / Ou-Yang, Xiao-Lu / Huang, Yu-Sheng / Li, Huan / Chen, Zi-Xin / Feng, Wen-Jun / Lian, Zhi-Ming / Wang, Zhen-Kui / Xian, Shao-Xiang / Yang, Zhong-Qi / Ye, Xiao-Han / Wang, Ling-Jun / Lu, Lu

    Journal of ethnopharmacology

    2022  Volume 298, Page(s) 115579

    Abstract: ... of morbidity and mortality, has become a social and economic problem worldwide over the last few decades. Zhen ... The purpose of this study was to investigate the effect and underlying mechanism of Zhen-Wu decoction ... effects of Zhen-Wu decoction were evaluated by echocardiography and tissue staining. RNA-Seq data were used ...

    Abstract Ethnopharmacological relevance: Cardiorenal syndrome type 4 (CRS type 4), with high rates of morbidity and mortality, has become a social and economic problem worldwide over the last few decades. Zhen-Wu decoction, a traditional medicine used in East Asia, has been widely used in the treatment of cardiovascular disease and kidney disease, and has shown potential therapeutic effects for the clinical treatment of CRS type 4. However, the underlying mechanism has not been extensively explored.
    Aim of the study: The purpose of this study was to investigate the effect and underlying mechanism of Zhen-Wu decoction on uremic cardiomyopathy, offering a potential target for clinical treatment of CRS type 4.
    Materials and methods: Five/six nephrectomized mice were utilized for experiments in vivo. The cardioprotective effects of Zhen-Wu decoction were evaluated by echocardiography and tissue staining. RNA-Seq data were used to investigate the potential pharmacological mechanism. The prediction of targets and active components was based on our previous strategy. Subsequently, the protective effect of the selected compound was verified in experiments in vitro.
    Results: Zhen-Wu decoction alleviated cardiac dysfunction and endothelial injury in 5/6 nephrectomized mice, and the mechanism may involve the inflammatory process and oxidative stress. The activation of the Nrf2 signaling pathway was predicted to be a potential target of Zhen-Wu decoction in protecting endothelial cells. Through our machine learning strategy, we found that lactiflorin as an ingredient in Zhen-Wu decoction, alleviates IS-induced endothelial cell injury by blocking Keap1 and activating Nrf2.
    Conclusions: The present study demonstrated that Zhen-Wu decoction and lactiflorin could protect endothelial cells against oxidative stress in mice after nephrectomy by activating the Nrf2 signaling pathway.
    MeSH term(s) Animals ; Computer Simulation ; Drugs, Chinese Herbal/pharmacology ; Drugs, Chinese Herbal/therapeutic use ; Endothelial Cells/metabolism ; Glycosides ; Kelch-Like ECH-Associated Protein 1/metabolism ; Mice ; Monoterpenes ; NF-E2-Related Factor 2/metabolism ; Uremia/drug therapy
    Chemical Substances Drugs, Chinese Herbal ; Glycosides ; Kelch-Like ECH-Associated Protein 1 ; Monoterpenes ; NF-E2-Related Factor 2 ; Nfe2l2 protein, mouse ; lactiflorin
    Language English
    Publishing date 2022-08-11
    Publishing country Ireland
    Document type Journal Article
    ZDB-ID 134511-4
    ISSN 1872-7573 ; 0378-8741
    ISSN (online) 1872-7573
    ISSN 0378-8741
    DOI 10.1016/j.jep.2022.115579
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Jin-Zhen oral liquid for pediatric coronavirus disease (COVID-19)

    Qian Dong / Hongmei Qiao / Huiyi Jiang / Lixiao Liu / Yanling Ge / Fang-Jiao Zong / Yanan Li / Bingzi Dong / Sujuan Hu / Dongmei Meng / Rong Jin / Xiangshi Wang / Hailing Chang / Xiaolong Xu / Chenjing Wang / Yu Cao / Han-Ting Zhang / Qingquan Liu

    Frontiers in Pharmacology, Vol

    A randomly controlled, open-label, and non-inferiority trial at multiple clinical centers

    2023  Volume 14

    Abstract: ... as a therapeutic option. Jin-Zhen Oral Liquid is widely used for pediatric acute bronchitis, while the efficacy and ... to moderate COVID-19. Children eligible for enrollment were randomly assigned in a 1:1 ratio to Jin-Zhen Oral ... randomly into the Jin-Zhen Oral Liquid (117 patients) and Jinhua Qinggan Granules (123 patients) groups ...

    Abstract Background: As the coronavirus disease 2019 (COVID-19) pandemic progressed, especially with the emergence of the Omicron variant, the proportion of infected children and adolescents increased significantly. Some treatment such as Chinese herbal medicine has been administered for COVID-19 as a therapeutic option. Jin-Zhen Oral Liquid is widely used for pediatric acute bronchitis, while the efficacy and safety in the treatment of pediatric COVID-19 are unclear.Methods: We conducted a randomized controlled, open-label, multicenter, non-inferiority clinical study involving hospitalized children with mild to moderate COVID-19. Children eligible for enrollment were randomly assigned in a 1:1 ratio to Jin-Zhen Oral Liquid (the treatment group) and Jinhua Qinggan Granules (the positive control group) and received the respective agent for 14 days, followed by a 14-day follow-up after discontinuation of the treatment. The primary efficacy endpoint was the time to first negative viral testing. The secondary endpoints were the time and rate of major symptoms disappearance, duration of hospitalization, and the proportion of symptoms changed from asymptomatic or mild to moderate or severe/critical illness. In addition, the safety end points of any adverse events were observed.Results: A total of 240 child patients were assigned randomly into the Jin-Zhen Oral Liquid (117 patients) and Jinhua Qinggan Granules (123 patients) groups. There was no significant difference of the baselines in terms of the clinical characteristics and initial symptoms between the two groups. After 14-day administration, the time to first negative viral testing in the Jin-Zhen group (median 6.0 days, 95% CI 5.0-6.0) was significantly shorter compared with the positive control Jinhua Qinggan Granules group (median 7.0 days, 95% CI 7.0-8.0). The time and rate of major clinical symptoms disappearance were comparable to the positive control. The symptom disappearance time of pharyngalgia and hospitalization duration were significantly shortened in the ...
    Keywords traditional Chinese medicine ; Jin-Zhen oral liquid ; pediatric COVID-19 ; randomized controlled clinical trial ; multiple clinical centers ; Therapeutics. Pharmacology ; RM1-950
    Subject code 610
    Language English
    Publishing date 2023-02-01T00:00:00Z
    Publisher Frontiers Media S.A.
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Book: Han-ying-zhen-jiu-cidian

    Wang, Hua

    = Chinese English dictionary of acupuncture and moxibustion

    1999  

    Title variant Chinese English dictionary of acupuncture and moxibustion ; Han ying zhen jiu cidian ; Chinese-English dictionary of acupuncture and moxibustion
    Author's details comp. Wang Hua
    Language Chinese ; English
    Size 127, 750 S. : Ill.
    Edition [2. ed.]
    Publisher Hubei Science and Technology Press u.a.
    Publishing place Wuhan shi
    Publishing country China
    Document type Book
    HBZ-ID HT012768313
    ISBN 7-5352-0914-9 ; 978-7-5352-0914-6
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  4. Article: Zhen-Wu decoction and lactiflorin, an ingredient predicted by in silico modelling, alleviate uremia induced cardiac endothelial injury via Nrf2 activation

    Liu, Xin / Li, Yue / Ni, Shi-Hao / Sun, Shu-Ning / Deng, Jian-Ping / Ou-Yang, Xiao-Lu / Huang, Yu-Sheng / Li, Huan / Chen, Zi-Xin / Feng, Wen-Jun / Lian, Zhi-Ming / Wang, Zhen-Kui / Xian, Shao-Xiang / Yang, Zhong-Qi / Ye, Xiao-Han / Wang, Ling-Jun / Lu, Lu

    Journal of ethnopharmacology. 2022 Nov. 15, v. 298

    2022  

    Abstract: ... a social and economic problem worldwide over the last few decades. Zhen-Wu decoction ... the effect and underlying mechanism of Zhen-Wu decoction on uremic cardiomyopathy, offering a potential ... in vivo. The cardioprotective effects of Zhen-Wu decoction were evaluated by echocardiography and tissue ...

    Abstract Cardiorenal syndrome type 4 (CRS type 4), with high rates of morbidity and mortality, has become a social and economic problem worldwide over the last few decades. Zhen-Wu decoction, a traditional medicine used in East Asia, has been widely used in the treatment of cardiovascular disease and kidney disease, and has shown potential therapeutic effects for the clinical treatment of CRS type 4. However, the underlying mechanism has not been extensively explored. The purpose of this study was to investigate the effect and underlying mechanism of Zhen-Wu decoction on uremic cardiomyopathy, offering a potential target for clinical treatment of CRS type 4. Five/six nephrectomized mice were utilized for experiments in vivo. The cardioprotective effects of Zhen-Wu decoction were evaluated by echocardiography and tissue staining. RNA-Seq data were used to investigate the potential pharmacological mechanism. The prediction of targets and active components was based on our previous strategy. Subsequently, the protective effect of the selected compound was verified in experiments in vitro. Zhen-Wu decoction alleviated cardiac dysfunction and endothelial injury in 5/6 nephrectomized mice, and the mechanism may involve the inflammatory process and oxidative stress. The activation of the Nrf2 signaling pathway was predicted to be a potential target of Zhen-Wu decoction in protecting endothelial cells. Through our machine learning strategy, we found that lactiflorin as an ingredient in Zhen-Wu decoction, alleviates IS-induced endothelial cell injury by blocking Keap1 and activating Nrf2. The present study demonstrated that Zhen-Wu decoction and lactiflorin could protect endothelial cells against oxidative stress in mice after nephrectomy by activating the Nrf2 signaling pathway.
    Keywords cardiomyopathy ; computer simulation ; echocardiography ; endothelial cells ; ingredients ; morbidity ; mortality ; oxidative stress ; prediction ; sequence analysis ; therapeutics ; traditional medicine ; uremia ; East Asia
    Language English
    Dates of publication 2022-1115
    Publishing place Elsevier B.V.
    Document type Article
    ZDB-ID 134511-4
    ISSN 1872-7573 ; 0378-8741
    ISSN (online) 1872-7573
    ISSN 0378-8741
    DOI 10.1016/j.jep.2022.115579
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  5. Article: Jin-Zhen oral liquid for pediatric coronavirus disease (COVID-19): A randomly controlled, open-label, and non-inferiority trial at multiple clinical centers.

    Dong, Qian / Qiao, Hongmei / Jiang, Huiyi / Liu, Lixiao / Ge, Yanling / Zong, Fang-Jiao / Li, Yanan / Dong, Bingzi / Hu, Sujuan / Meng, Dongmei / Jin, Rong / Wang, Xiangshi / Chang, Hailing / Xu, Xiaolong / Wang, Chenjing / Cao, Yu / Zhang, Han-Ting / Liu, Qingquan

    Frontiers in pharmacology

    2023  Volume 14, Page(s) 1094089

    Abstract: Background: ...

    Abstract Background:
    Language English
    Publishing date 2023-02-27
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2587355-6
    ISSN 1663-9812
    ISSN 1663-9812
    DOI 10.3389/fphar.2023.1094089
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Reply to Zhen and Yu: Cognitive control as questionable proxy for deliberation in honest behaviors.

    Bellucci, Gabriele / Wang, Chongxiang / Sai, Liyang / Krueger, Frank

    Proceedings of the National Academy of Sciences of the United States of America

    2022  Volume 119, Issue 27, Page(s) e2203613119

    MeSH term(s) Brain/anatomy & histology ; Brain/physiology ; Cognition ; Deception ; Humans
    Language English
    Publishing date 2022-06-21
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.2203613119
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Fu Fang Zhen Zhu Tiao Zhi Capsules Protect against Myocardial Ischemia by Inhibiting Cardiomyocyte Pyroptosis.

    Shao, Xiaoqi / Huang, Bingying / Tan, Huiling / Wang, Ruonan / Huang, Xueying / Diao, Hongtao / Cheng, Jiawen / Sun, Mengxian / Wang, Dongwei / Wu, Kaili / Yan, Meiling / Rong, Xianglu / Zhang, Yue / Guo, Jiao

    Evidence-based complementary and alternative medicine : eCAM

    2022  Volume 2022, Page(s) 4752360

    Abstract: Background: Fu Fang Zhen Zhu Tiao Zhi (FTZ) is a traditional Chinese herbal prescription widely ...

    Abstract Background: Fu Fang Zhen Zhu Tiao Zhi (FTZ) is a traditional Chinese herbal prescription widely used to treat dyslipidemia, metabolic diseases, and diabetic coronary disorders. Cardiomyocyte death and loss of regenerative ability cause cardiac dysfunction and heart failure. FTZ can effectively treat diabetic cardiomyopathy and macrovascular diseases; however, the mechanism behind the phenomenon is still unclear. Here, we determined the mechanism of action of FTZ in treating myocardial infarction.
    Methods: Male C57BL/6 mice were treated with 2.4 or 1.2 g/kg FTZ, or administered saline by oral gavage daily for four weeks, and a 24-hour ligation was administered to the artery. Echocardiography was used to evaluate cardiac function. Hematoxylin and eosin and Evans blue/triphenyltetrazolium chloride staining were carried out by staining the cardiac tissue, used to evaluate cardiac function and infarct size. Using western blotting and reverse transcriptase-polymerase chain reaction, we determined the relative levels of NOD-like receptor protein (NLRP) 3, ASC, cleaved caspase-l (C-Caspase-1), GSDMD, and GSDMD-N. TUNEL, immunohistochemical, and immunofluorescence staining were used to determine cell death and NLRP3 expression. An enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of interleukin (IL)-1
    Results: FTZ reduced ischemia-induced cardiomyocyte cell death
    Conclusion: FTZ could preserve cardiac function resulting from ischemic insult by inhibiting pyroptosis, which was partially reversed by NLRP3 overexpression, indicating that NLRP3 could be a potential target of FTZ in treating myocardial infarction.
    Language English
    Publishing date 2022-11-02
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2171158-6
    ISSN 1741-4288 ; 1741-427X
    ISSN (online) 1741-4288
    ISSN 1741-427X
    DOI 10.1155/2022/4752360
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Zhen Wu decoction represses renal fibrosis by invigorating tubular NRF2 and TFAM to fuel mitochondrial bioenergetics.

    Zheng, Min / Hu, Zhengyang / Wang, Yibin / Wang, Chunyan / Zhong, Chao / Cui, Weiwei / You, Junxiong / Gao, Baogui / Sun, Xuegang / La, Lei

    Phytomedicine : international journal of phytotherapy and phytopharmacology

    2022  Volume 108, Page(s) 154495

    Abstract: Background: Zhen Wu Decoction (ZWD) is a prescription from the classical text "Treatise ...

    Abstract Background: Zhen Wu Decoction (ZWD) is a prescription from the classical text "Treatise on Exogenous Febrile Disease" and has been extensively used to control kidney diseases since the time of the Eastern Han Dynasty.
    Hypothesis: We hypothesized that ZWD limits tubular fibrogenesis by reinvigorating tubular bio-energetic capacity.
    Study design / methods: A mouse model of chronic kidney disease (CKD) was established using unilateral ureteral obstruction (UUO). Three concentrations of ZWD, namely 25.2 g/kg (high dosage), 12.6 g/kg (middle dosage), and 6.3 g/kg (low dosage), were included to study the dose-effect relationship. Real-time qPCR was used to observe gene transcription in blood samples from patients with CKD. Different siRNAs were designed to study the role of mitochondrial transcription factor A (TFAM) and nuclear factor (erythroid-derived 2)-related factor 2 (NRF2) in transforming growth factor (TGF)-β1 induced fibrogenesis and mitochondrial damage.
    Results: We showed that ZWD efficiently attenuates renal function impairment and reduces renal interstitial fibrosis. TFAM and NRF2 were repressed, and the stimulator of interferon genes (STING) was activated in CKD patient blood sample. We further confirmed that ZWD activated TFAM depended on NRF2 as an important negative regulator of STING in mouse kidneys. Treatment with ZWD significantly reduced oxidative stress and inflammation by regulating the levels of oxidative phosphorylation (OXPHOS) and pro-inflammatory factors, such as interleukin-6, interleukin-1β, tumor necrosis factor receptor 1, and mitochondrial respiratory chain subunits. NRF2 inhibitors can weaken the ability of ZWD to increase TFAM expression and heal injured mitochondria, playing a similar role to that of STING inhibitors. Our study showed that ZWD elevates the expression of TFAM and mitochondrial respiratory chain subunits by promoting NRF2 activation, after suppressing mitochondrial membrane damage and cristae breakdown and restricting mitochondrial DNA (mtDNA) leakage into the cytoplasm to reduce STING activation.
    Conclusion: ZWD maintains mitochondrial integrity and improves OXPHOS which represents an innovative insight into "strengthening Yang-Qi" theory. ZWD limits tubular fibrogenesis by reinvigorating tubular bioenergetic capacity.
    MeSH term(s) Animals ; Mice ; DNA, Mitochondrial/genetics ; DNA-Binding Proteins/genetics ; DNA-Binding Proteins/metabolism ; Energy Metabolism ; Fibrosis ; High Mobility Group Proteins/genetics ; High Mobility Group Proteins/metabolism ; Kidney ; Mitochondria/metabolism ; NF-E2-Related Factor 2/genetics ; NF-E2-Related Factor 2/metabolism ; Renal Insufficiency, Chronic/drug therapy ; Ureteral Obstruction/pathology ; Drugs, Chinese Herbal/pharmacology
    Chemical Substances DNA, Mitochondrial ; DNA-Binding Proteins ; High Mobility Group Proteins ; NF-E2-Related Factor 2 ; Tfam protein, mouse ; Drugs, Chinese Herbal ; Nfe2l2 protein, mouse
    Language English
    Publishing date 2022-10-08
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1205240-1
    ISSN 1618-095X ; 0944-7113
    ISSN (online) 1618-095X
    ISSN 0944-7113
    DOI 10.1016/j.phymed.2022.154495
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Correction: Zhen, Z. et al. NaCl Inhibits Citrinin and Stimulates Monascus Pigments and Monacolin K Production. Toxins 2019, 11, 118.

    Zhen, Zhixin / Xiong, Xiaoqian / Liu, Yingbao / Zhang, Jialan / Wang, Shaojin / Li, Li / Gao, Mengxiang

    Toxins

    2019  Volume 11, Issue 4

    Abstract: The authors wish to make the following correction to their paper [ ... ]. ...

    Abstract The authors wish to make the following correction to their paper [...].
    Language English
    Publishing date 2019-03-27
    Publishing country Switzerland
    Document type Published Erratum
    ZDB-ID 2518395-3
    ISSN 2072-6651 ; 2072-6651
    ISSN (online) 2072-6651
    ISSN 2072-6651
    DOI 10.3390/toxins11040183
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Systems Pharmacology and In Silico Docking Analysis Uncover Association of CA2, PPARG, RXRA, and VDR with the Mechanisms Underlying the Shi Zhen Tea Formula Effect on Eczema

    Zhen-Zhen Wang / Yuan Jia / Kamal D. Srivastava / Weihua Huang / Raj Tiwari / Anna Nowak-Wegrzyn / Jan Geliebter / Mingsan Miao / Xiu-Min Li

    Evidence-Based Complementary and Alternative Medicine, Vol

    2021  Volume 2021

    Abstract: ... immune disorders, and deficiencies in skin barrier function. Shi Zhen Tea (SZT), derived ...

    Abstract Eczema is a complex chronic inflammatory skin disease impacted by environmental factors, infections, immune disorders, and deficiencies in skin barrier function. Shi Zhen Tea (SZT), derived from traditional Chinese medicine Xiao-Feng-San, has shown to be an effective integrative therapy for treating skin lesions, itching, and sleeping loss, and it facilitates reduction of topical steroid and antihistamine use in pediatric and adult patients with severe eczema. Yet, its active compounds and therapeutic mechanisms have not been elucidated. In this study, we sought to investigate the active compounds and molecular mechanisms of SZT in treating eczema using systems pharmacology and in silico docking analysis. SZT is composed of 4 medicinal herbs, Baizhu (Atractylodis macrocephalae rhizome), Jingjie (Schizonepetae herba), Kushen (Sophorae flavescentis radix), and Niubangzi (Arctii fructus). We first identified 51 active compounds from SZT and their 81 potential molecular targets by high-throughput computational analysis, from which we identified 4 major pathways including Th17 cell differentiation, metabolic pathways, pathways in cancer, and the PI3K-Akt signaling pathway. Through network analysis of the compound-target pathway, we identified hub molecular targets within these pathways including carbonic anhydrase II (CA2), peroxisome proliferator activated receptor γ (PPAR γ), retinoid X receptor α (RXRA), and vitamin D receptor (VDR). We further identified top 5 compounds including cynarine, stigmasterin, kushenol, β-sitosterol, and (24S)-24-propylcholesta-5-ene-3β-ol as putative key active compounds on the basis of their molecular docking scores with identified hub target proteins. Our study provides an insight into the therapeutic mechanism underlying multiscale benefits of SZT for eczema and paves the way for developing new and potentially more effective eczema therapies.
    Keywords Other systems of medicine ; RZ201-999
    Subject code 540
    Language English
    Publishing date 2021-01-01T00:00:00Z
    Publisher Hindawi Limited
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top